University of Pittsburgh: Using Precision Medicine to Improve Pancreatic Cancer Outcomes

The University of Pittsburgh has released findings from two studies that may improve outcomes for the very serious and limited treatment options pancreatic cancer condition. In the first study, the researchers used genomic profiling to identify targeted therapies for the patients and in the other researchers used existing drugs that are used to treat similar genetic conditions.

Half of the patients who “received genomic-guided therapy experienced significant clinical benefit with improvement in overall survival.” Read more at the University of Pittsburgh website.

Published by

Dave Bove

Innovation Lover, Singer, Actor, Songwriter, Guitarist (poor one), Artist, Computer Geek, and Jolly (sometimes) Rancher...

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s